Staff Platform Engineer (Compute Migration) at HeartFlow

San Francisco, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Medical Technology, CardiovascularIndustries

Requirements

8+ years of experience in Platform, Infrastructure, or DevOps Engineering roles, with significant time spent on large-scale compute migrations
Expert-level proficiency in Kubernetes (design, deployment, operations, networking, security, and scaling)
Deep, hands-on experience with AWS compute services, particularly AWS Lambda and ECS/Fargate, and a clear understanding of their operational models and scaling

Responsibilities

Define the technical roadmap, migration patterns, and reference architectures for moving Lambda functions and ECS services to our self-managed or managed Kubernetes clusters on AWS EKS
Develop robust, scalable, and automated solutions for running event-driven, serverless-like workflows on Kubernetes, potentially utilizing technologies like KEDA or similar cloud-native tools
Use Terraform/Terragrunt and Helm to build and manage the necessary underlying Kubernetes infrastructure, networking, and deployment tooling
Partner closely with engineering teams to understand their unique workload requirements, provide consultation on re-platforming best practices, and develop standardized tools (e.g., CI/CD pipelines) for easy migration and deployment
Benchmark migrated services, optimize resource requests/limits, and implement advanced observability (monitoring, logging, tracing) solutions to ensure parity or improvement in service SLOs
Establish best practices, guardrails, and documentation for running event-based compute on Kubernetes to ensure a smooth transition and sustainable operation post-migration

Skills

Kubernetes

AWS

AWS Lambda

ECS

Cloud-Native

Platform Engineering

Compute Migration

Serverless

Containerized Workflows

Event-Driven

HeartFlow

Non-invasive cardiac testing for heart disease

About HeartFlow

HeartFlow provides a non-invasive cardiac test that helps visualize a patient's coronary arteries in detail. This technology allows physicians to diagnose and treat heart disease more effectively without the need for invasive procedures, which reduces risks for patients and costs for healthcare providers. HeartFlow's main clients are healthcare professionals seeking safer diagnostic methods. The company offers several analyses, including FFRCT Analysis and Plaque Analysis, all of which have received FDA clearance and are available in multiple countries, including the United States, the United Kingdom, Japan, and Canada. Unlike many competitors, HeartFlow focuses on providing a comprehensive suite of analyses that enhance treatment planning. The goal of HeartFlow is to improve cardiovascular care by making it safer and more efficient for both patients and healthcare providers.

Redwood City, CaliforniaHeadquarters

2010Year Founded

$858.5MTotal Funding

SERIES_FCompany Stage

HealthcareIndustries

501-1,000Employees

Benefits

Remote Work Options

Stock Options

401(k) Company Match

Risks

Emerging AI-driven competitors could threaten HeartFlow's market share.

Algorithmic bias in AI models could lead to inaccurate diagnoses.

Integration into healthcare systems may face resistance due to complexity and cost.

Differentiation

HeartFlow offers the only combined anatomy, physiology, and plaque analysis for heart disease.

HeartFlow's non-invasive FFRCT Analysis is FDA-cleared and widely available globally.

HeartFlow's AI-driven technology provides personalized 3D heart models for precise diagnostics.

Upsides

HeartFlow closed a $215 million Series F funding round in April 2023.

The global non-invasive cardiac imaging market is projected to grow significantly.

HeartFlow's technology aligns with the trend towards value-based care in healthcare.

Land your dream remote job 3x faster with AI

Try Jobo Free